CD34(+)CD38(−)CD123(+) Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents

The prognostic impact of immunophenotypic CD34(+)CD38(−)CD123(+) leukemic stem cell (iLSC) frequency at diagnosis has been demonstrated in younger patients treated by intensive chemotherapy, however, this is less clear in older patients. Furthermore, the impact of iLSC in patients treated by hypomet...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergez, François, Nicolau-Travers, Marie-Laure, Bertoli, Sarah, Rieu, Jean-Baptiste, Tavitian, Suzanne, Bories, Pierre, Luquet, Isabelle, De Mas, Véronique, Largeaud, Laetitia, Sarry, Audrey, Huguet, Françoise, Delabesse, Eric, Bérard, Emilie, Récher, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281486/
https://www.ncbi.nlm.nih.gov/pubmed/32384744
http://dx.doi.org/10.3390/cancers12051174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281486/
https://www.ncbi.nlm.nih.gov/pubmed/32384744
http://dx.doi.org/10.3390/cancers12051174

Ejemplares similares